← Leaderboards
Andrew Paul Vandemark
Brookhaven Science Assoc-Brookhaven Lab
$2,292,418
Attributed
$3,953,276
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.8K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,953,276 · 7
By mechanism
R01$3,372,685 · 2
R21$426,299 · 1
R03$144,326 · 1
P41$9,966 · 3
Top collaborators
- Kirill Kiselyov3 shared
- Amantha Thathiah3 shared
- Donna M Huryn2 shared
- David Ryan Koes2 shared
- Partha Roy2 shared
Most similar at Brookhaven Science Assoc-Brookhaven Lab
Same institution · by research overlap
- Paul Vaska$2,271,126
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposComplexCellsProteinsStructureMolecularMediatingMutantMutationPlayBiochemicalSignal TransductionBindingBinding (Molecular Function)ResponseDefectHomeostasisGenesHuman DiseaseMorphologyRegulationMolecular ConformationActinsCell Physiology
Grant awards (15)
Role of mitochondrial GDAP1 in Alzheimer's disease$661,566
R01 · FY2025 · AG
Role of mitochondrial GDAP1 in Alzheimer's disease$675,067
R01 · FY2024 · AG
Structure of GDAP1 bound to a product of lipid peroxidation$72,072
R03 · FY2024 · NS · contact PI
Role of mitochondrial GDAP1 in Alzheimer's disease$675,067
R01 · FY2023 · AG
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye$155,520
R21 · FY2023 · EY
Structure of GDAP1 bound to a product of lipid peroxidation$72,254
R03 · FY2023 · NS · contact PI
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye$270,779
R21 · FY2022 · EY
The Structural Basis of Shroom-Mediated Cell Contractility$275,613
R01 · FY2015 · GM · contact PI
The Structural Basis of Shroom-Mediated Cell Contractility$275,969
R01 · FY2014 · GM · contact PI
The Structural Basis of Shroom-Mediated Cell Contractility$266,645
R01 · FY2013 · GM · contact PI
The Structural Basis of Shroom-Mediated Cell Contractility$276,652
R01 · FY2012 · GM · contact PI
The Structural Basis of Shroom-Mediated Cell Contractility$266,106
R01 · FY2011 · GM · contact PI
THE PAF1 TRANSCRIPTION ELONGATION COMPLEX$1,921
P41 · FY2011 · RR · contact PI
THE PAF1 TRANSCRIPTION ELONGATION COMPLEX$4,643
P41 · FY2010 · RR · contact PI
DSHRM SD2 DOMAIN$3,402
P41 · FY2010 · RR · contact PI